Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 1, 2010, Pages 274-281

  Esteves, M A ^a   Fragiadaki, I ^b   Lopes, R ^c,d   Scoulica, E ^b   Cruz, M E M ^c,d  

^a INETI   (Portugal)

^b UNIVERSITY OF CRETE   (Greece)

^c RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^d Research Institute for Medicines and Pharmaceutical Sciences   (Portugal)

Author keywords

Biological activity; Dinitroanilines; Leishmania; Trifluralin analogues

Indexed keywords

1 (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)PIPERIDINE; 2 (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYLAMINO)PHENOL; 2 [(2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)BUTYLAMINO]ETHANOL; 2 [(2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)ETHYLAMINO]ETHANOL; 2 [(2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)HEXYLAMINO]ETHANOL; 2 [(2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)PENTYLAMINO]ETHANOL; 2 [(2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)PROPYLAMINO]ETHANOL; 3 (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYLAMINO)PHENOL; 4 (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)MORPHOLINE; 4 (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYLAMINO)PHENOL; ANTILEISHMANIAL AGENT; MILTEFOSINE; N (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)CYCLOHEXYLAMINE; N (2,6 DINITRO 4 TRIFLUOROMETHYLPHENYL)ISOPROPYLAMINE; TRIFLURALIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEMOLYSIS; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN;

ANTIPROTOZOAL AGENTS; CELL DEATH; CELL LINE; ERYTHROCYTES; HEMOLYSIS; HUMANS; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIASIS; TRIFLURALIN;

LEISHMANIA DONOVANI; LEISHMANIA INFANTUM;

EID: 72149117690     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.10.059     Document Type: Article

References (14)

1. Davies P.K., Croft S.L., and Sundar S. Br. Med. J. 326 (2003) 377
2. Croft S.L., Seifert K., and Yardley V. Indian J. Med. Res. 123 (2006) 399
3. Pérez-Victória F.J., Sánchez-Cañete M.P., Seifert K., Croft S.L., Sundar S., Castanys S., and Gamarro F. Drug Resist. Update. 9 (2006) 26
4. Ouellette M., Drummelsmith J., and Papadopoulou B. Drug Resist. Update. 7 (2004) 257
5. Croft S.L., and Coombs G.H. Trends Parasitol. 19 (2003) 502
6. Chan M.M., Tzeng J., Emge T.J., Ho C.T., and Fong D. Antimicrob. Agents Chemother. 37 (1993) 1909
7. Mamy E., Barriuso B., and Gabrielle B. Pest Manag. Sci. 61 (2005) 905
8. Carvalheiro M., Jorge J., Eleutério C., Pinhal A.F., Sousa A.C., Morais J.G., and Cruz M.E.M. Eur. J. Pharm. Biopharm. 71 (2009) 292
9. Marques C., Carvalheiro M., Pereira M.A., Jorge J., Cruz M.E.M., and Santos-Gomes G.M. Vet. J. 178 (2008) 133
10. Benbow J.W., Bernberg E.L., Korda A., and Mead J.R. Antimicrob. Agents Chemother. 42 (1998) 339
11. Al-Howsaway H.O.M., Fathalla M.F., El-Bardan A.A., and Hamed E.A. J. Chem. Res. (2007) 509
12. Saavedra J.E. J. Org. Chem. 50 (1985) 2271
13. Hills, M.; Hudson, C.; Smith, P. G., Working Paper 2.8.5, World Health Organization: Geneva, Switzerland, 1986.
14. Huber W., and Koella J.C. Acta Trop. 55 (1993) 257